Literature DB >> 12590576

Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions.

Xiaoda Yang1, Yongbo Hu, Daniel H Yin, Mary A Turner, Mengmeng Wang, Ronald T Borchardt, P Lynne Howell, Krzysztof Kuczera, Richard L Schowen.   

Abstract

S-Adenosylhomocysteine hydrolase (AdoHcy hydrolase) crystallizes from solutions containing the intermediate analogue neplanocin A with the analogue bound in its 3'-keto form at the active sites of all of its four subunits and the four tightly bound cofactors in their reduced (NADH) state. The enzyme is in the closed conformation, which corresponds to the structure in which the catalytic chemistry occurs. Examination of the structure in the light of available, very detailed kinetic studies [Porter, D. J., Boyd, F. L. (1991) J. Biol. Chem. 266, 21616-21625. Porter, D. J., Boyd, F. L. (1992) J. Biol. Chem. 267, 3205-3213. Porter, D. J. (1998) J. Biol. Chem. 268, 66-73] suggests elements of the catalytic strategy of AdoHcy hydrolase for acceleration of the reversible conversion of AdoHcy to adenosine (Ado) and homocysteine (Hcy). The enzyme, each subunit of which possesses a substrate-binding domain that in the absence of substrate is in rapid motion relative to the tetrameric core of the enzyme, first binds substrate and ceases motion. Probably concurrently with oxidation of the substrate to its 3'-keto form, the closed active site is "sealed off" from the environment, as indicated by a large (10(8)(-)(9)-fold) reduction in the rate of departure of ligands, a feature that prevents exposure of the labile 3'-keto intermediates to the aqueous environment. Elimination of the 5'-substituent (Hcy in the hydrolytic direction, water in the synthetic direction) generates the central intermediate 4',5'-didehydro-5'-deoxy-3'-ketoadenosine. Abortive 3'-reduction of the central intermediate is prevented by a temporary suspension of all or part of the redox catalytic power of the enzyme during the existence of the central intermediate. The abortive reduction is 10(4)-fold slower than the productive reductions at the ends of the catalytic cycle and has a rate constant similar to those of nonenzymic intramolecular model reactions. The mechanism for suspending the redox catalytic power appears to be a conformationally induced increase in the distance across which hydride transfer must occur between cofactor and substrate, the responsible conformational change again being that which "seals" the active site. The crystal structure reveals a well-defined chain of three water molecules leading from the active site to the subunit surface, which may serve as a relay for proton exchange between solvent and active site in the closed form of the enzyme, permitting maintenance of active-site functional groups in catalytically suitable protonation states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590576     DOI: 10.1021/bi0262350

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  A single mutation at Tyr143 of human S-adenosylhomocysteine hydrolase renders the enzyme thermosensitive and affects the oxidation state of bound cofactor nicotinamide-adenine dinucleotide.

Authors:  Robert Beluzić; Mario Cuk; Tea Pavkov; Ksenija Fumić; Ivo Barić; S Harvey Mudd; Igor Jurak; Oliver Vugrek
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

2.  Evaluation of NAD(H) analogues as selective inhibitors for Trypanosoma cruzi S-adenosylhomocysteine hydrolase.

Authors:  Qing-Shan Li; Sumin Cai; Jianwen Fang; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

3.  The rationale for targeting the NAD/NADH cofactor binding site of parasitic S-adenosyl-L-homocysteine hydrolase for the design of anti-parasitic drugs.

Authors:  Sumin Cai; Qing-Shan Li; Jianwen Fang; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

4.  S-adenosylhomocysteine analogues with the carbon-5' and sulfur atoms replaced by a vinyl unit.

Authors:  Daniela Andrei; Stanislaw F Wnuk
Journal:  Org Lett       Date:  2006-10-26       Impact factor: 6.005

5.  S-adenosyl-L-homocysteine hydrolase from a hyperthermophile (Thermotoga maritima) is expressed in Escherichia coli in inactive form - Biochemical and structural studies.

Authors:  Krzysztof Brzezinski; Justyna Czyrko; Joanna Sliwiak; Edyta Nalewajko-Sieliwoniuk; Mariusz Jaskolski; Boguslaw Nocek; Zbigniew Dauter
Journal:  Int J Biol Macromol       Date:  2017-06-16       Impact factor: 6.953

6.  Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 3. Role of lysyl and tyrosyl residues of the C-terminal extension.

Authors:  Sumin Cai; Jianwen Fang; Qing-Shan Li; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

7.  S-adenosylhomocysteine hydrolase (AHCY) deficiency: two novel mutations with lethal outcome.

Authors:  Oliver Vugrek; Robert Beluzić; Nikolina Nakić; S Harvey Mudd
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

8.  Synthesis of 5'-functionalized nucleosides: S-Adenosylhomocysteine analogues with the carbon-5' and sulfur atoms replaced by a vinyl or halovinyl unit.

Authors:  Stanislaw F Wnuk; Pablo R Sacasa; Elzbieta Lewandowska; Daniela Andrei; Sumin Cai; Ronald T Borchardt
Journal:  Bioorg Med Chem       Date:  2008-04-12       Impact factor: 3.641

9.  Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors.

Authors:  Manchi C M Reddy; Gokulan Kuppan; Nishant D Shetty; Joshua L Owen; Thomas R Ioerger; James C Sacchettini
Journal:  Protein Sci       Date:  2008-09-24       Impact factor: 6.725

10.  Ocimum Sanctum Linn: A Potential Adjunct Therapy for Hyperhomocysteinemia-Induced Vascular Dementia.

Authors:  Jagadeesh Prasad Pasangulapati; Arun Reddy Ravula; Dinesh Reddy Kanala; Shanmukhi Boyina; Kiran Gangarapu; Hemanth Kumar Boyina
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.